NCT04073082

Brief Summary

The aim of this study is to retrospectively evaluate the effectiveness and safety of Er:YAG laser for treatment of different gynecological indication, e.g. genital lesions, Bartholin's cyst, condyloma, episiotomy scars, lesions of hydradenitis suppurativa and use of laser in genital surgery used in private practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 24, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 27, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2020

Completed
Last Updated

August 30, 2019

Status Verified

August 1, 2019

Enrollment Period

6 months

First QC Date

August 27, 2019

Last Update Submit

August 28, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Safety - occurence of adverse effects.

    Recording if any adverse effects occur.

    [1 year]

  • Efficacy - number of laser treatments.

    Number of laser treatments needed for lesion clearance.

    [1 year]

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Retrospective study assessing the safety and efficacy of laser use in treatment of different gynecology indications.

You may qualify if:

  • patients with any of the selected gynecology indications, treated with laser in the period 2013-2018
  • signed informed consent

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Juna

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Conditions

Herpes GenitalisCondylomata AcuminataLichen Sclerosus et AtrophicusUterine Cervical DysplasiaHidradenitis Suppurativa

Condition Hierarchy (Ancestors)

Sexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsHerpes SimplexHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGenital Diseases, MaleMale Urogenital DiseasesPapillomavirus InfectionsWartsSkin Diseases, ViralTumor Virus InfectionsSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsLichenoid EruptionsSkin Diseases, PapulosquamousPrecancerous ConditionsNeoplasmsUterine Cervical DiseasesUterine DiseasesSkin Diseases, BacterialBacterial InfectionsBacterial Infections and MycosesSuppurationHidradenitisSweat Gland Diseases

Study Officials

  • Urška Urska.Bizjak-Ogrinc@juna.si, MD, MSc

    Specialist in obstetrics and gynecology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2019

First Posted

August 29, 2019

Study Start

July 24, 2019

Primary Completion

January 24, 2020

Study Completion

January 24, 2020

Last Updated

August 30, 2019

Record last verified: 2019-08

Locations